As per file enclosed.

VENUS 6nioy gncoualions VRL/S EC/EXc llA N G E 20. 08 2026 National Stock Exchange of India Ltd. BSE Limited 5th Floor, Exchange Plaza 25th Floor, Phiroze Jeejeebhoy Towers, Dalal Bandra (E), Street Mumbai- 400 051 fvlumbai Script Code: VENUSREM Script Code: 526953 Sub.: Proceedings of 37th Annual General Meeting of Venus Remedies Limited, held on 20th August 2026 at 11.30 am pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 through Video Conferencing/other VIsual Audio Means ("VC/OVAM") Dear Sir/ Madam, Pursuant to Regulation 30 of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule Ill Part A, we wish to inform you that the 37th Annual General Meeting of the Company was held on Thursday, 20th August, 2026 at 11 :30 a.in, through Video Conferencing/other Visual Audio Means ("VC/OVAM") facility, The meeting was held in compliance with the applicable circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The details as required under Regulation 30 read with Part A Para (A)(13) of Schedule Ill of the Listing Regulations in the form of proceedings of the AGM, are enclosed as Annexure Kindly take it on your record. Thanking you Yours faithfully, for VENUS REMEDIES LIMITED Neha (Company Secretary) M. No. F8374 VENUS REMEDIES LIMITED Corponte Omc. : Uult.I : 51-52. Industnal Area, Phase-I, Panchkula (Hry.) 51-52, Industrial Area, Phase-I, Panchkula (Hry.) 134113, India Tel : +91-172-2933090, 2933094, Fax : +91-172-2565566 134113, India Reed. Once : Uult-Il : SCO 857, Cabin No.10, 2nd Floor, NAC, Manimajra, gIL?oo,plnaldaun:t:1:lgls(fits,)JF7=?1oa!TIE:1I:.Phase-"Extn,, Chandigarh (U T ) 160101, India Tel. : +91 -1792-242100. 242101 Website . www.venusremedies.coni www,vmrcindia.com Uult-V : VENUS PHARMA Gmbll email . Info(/i v€nusremedies com ©£NET% AM Bahnhof I-3, D-S9368. GIN No L24232Clil989PLC009705 Werne, Germany VENUS Gnioy gnnoualions Annexure A SulvIMARY OF PROCEEDINGS OF 37th ANNUAL GENERAL MEETING The 37th Annual General Meeting of the Company was held on 20th August 2026 at 11.30 am through video Conferencing/other Vlsual Audio Means ("VC/OVAM") facility. The following Board of Directors and Key Managerial personnel present at the 37th AGM of the Company: Sr. No. Names Designation Mr. Pawan Chaudhary Chairman & Managing Director 2. Mr. Peeyush Jain Deputy Managing Director 3. Mr. Ashutosh Jain Executive Di rector 4. Mr. Akshansh Chaudhary Executive Di rector 5. Saransh Chaudhary Executive Director 6. Mr. NPS Monga Independent Director and Chairman of Audit Committee 7. Dr.(Mrs.) Savita Gupta Independent Director and Chairman of Stakeholder Relationship Committee 8. Mr. Navdeep Sud Independent Director 9. Dr, Anil Kumar Independent Director 10. Dr. Gurminder Singh Bedi Independent Director Mr. Prince Chadha Secretarial Auditor and Scrutinizer 12. Mr. Anurag Verma StatutoryAuditor 13. Mrs. Neha Kodan Company Secretary 14. Mr. Rakesh Pandit Head-Co rporate Secretarial VENUS REMEDIES LIMITED Corpor.te omc. : Uult-I : 51-52, Industrial Area, Phase-I, Panchkula (Hry.) i:1-52+5T|u7S±r2alg3¥8S#33e3-6'9E:nFcfkuJS|T]72)_i3€55%'6[nd'a 134113 , India R®fd. Omc. : Uult.II : SCO 857, Cabin No. 10, 2nd Floor, NAC, Manimajra, E#:To°iprfud£S,tE:LE;Sifitcp')J]h7a3Toa3T,::::,Phase-I,(Extn) Chandigarh (U.T.) 160101, India Tel. . +91-1792-242100` 242101 Website . www venusremedies.corn Unit.V : www.vmrcindia com email . info:ct`renusremedies.com VENUS PHARMA GmbH RE#tEEE AM Bahnhof 1-3, D-59368, GIN No L24232CH1989PLC009705 Weme, Germany VENUS Grif oy g nneualions Total 59 members have attended the meeting which was held through video Conferencing/other visual Audio Means ("VC/OVAM") facility, Accordingly, the requisite quorum being present, the meeting was called in order. The Company Secretary welcomed the Shareholders and apprised them of the procedural and technical guidelines relating to participation in the AGM through Video Conferencing. The Company Secretary informed the Shareholders that the Company had arranged for electronic voting through the remote evoting system provided by M/s. MUFG lntime India Pvt. Ltd. The e- voting period commenced on 17th August 2026 at 9:00 a.in. (lsT) and concluded on 19th August 2026 at 5:00 p.in. (IST)." Further, for Shareholders who were present at the Annual General Meeting (AGM) and who hadn't participated in electronic voting, an option was given to cast their votes electronically within the final 15 minutes after the conclusion of AGM's proceedings. The Shareholders were duly informed that Mr. Prince Chadha, Practising Company Secretary of M/s. P. Chadha & Associates, had been appointed by the Board of Directors to act as the Scrutiniser for the AGM. He was entrusted with the responsibility of overseeing and scrutinising the electronic voting process and related procedures during the AGM. Thereafter, the Chairman proceeded to address the Shareholders. In his address, he presented an overview of the Company's performance during the Financial Year 2025-2026, highlighted the key achievements since the previous AGM, and outlined the Company's future outlook and growth prospects The following resolutions set out in the Notice convening the AGM were put to vote by remote e- voting and voting during the Meeting: 1. Ordinary Resolution: To receive, consider and adopt the audited standalone financial statements of the Company for the financial year ended 318t March 2026 and the reports of the Board of Di- rectors and Auditor thereon. 2. Ordinary Resolution: To receive, consider and adopt the audited consolidated financial state- ments of the Company for the financial year ended 318t March 2026 and the report of the Auditor thereon. 3. Ordinary Resolution: To declare final dividend of Rs.10/-(Rupees Ten only) per equity share (i.e. 100% on the face value of 10/-). 4. Ordinary Resolution: To re-appoint Mr. Ashutosh Jain (DIN: 01336895) as director liable to retire by rotation. 5. Ordinary Resolution: To re-appoint Mr. Peeyush Jain (DIN: 00440361) as director liable to retire by rotation. VENUS REMEDIES LIMITED Corpor.t. omc. : Uult.I : 51-52, Industrial Area, Phase-I, Panchkula (Hry.) 51-52, Industrial Area, Phase-I, Panchkula (Hry ) 134113, India Tel : +91-172-2933090, 2933094, Fax : +91-172-2565566 134113, India R.8d. Omc. : Ualt-II : SCO 857, Cabin No 10, 2nd Floor, NAG, Manima]ra, g#1a?oo,pl:faun:tE:lE,s(fits,)T7a3=oa!:,,E:1I:,Phase-HExtn). Chandigarh (U.T.) 160101, India Tel : +91-1792-242100. 242101 Website : www.venusremedies corn Uult-V : www.vmrcindia,com VENUS PHARMA GmbH email . Imf t{venusremedies com AM Bahnhof 1-3, D-59368, ©£NEeroHs CIN No L24232CH1989PLC009705 Werne, Germany VENUS Gnioy gnlioualian 6. Ordinary Resolution: To ratify the remuneration of Rs.1,10,000/-per annum for cost auditors for the financial year 2026-27. 7. Special Resolution: To appoint Mr. Saransh Chaudhary as Executive Director (Whole Time Di- rector) of the Company for a term of five years. 8. Special Resolution: To appoint Dr. Gurminder Singh as Non-Executive Independent Director of the Company for the term of five years. 9. Special Resolution: To Re-appoint Dr. (Mrs.) Manu Chaudhary as joint Managing Director of the Company for five years 10. Special Resolution: To Re-appoint Dr. (Mrs.) Savita Gupta as Non-Executive Independent Direc- tor of the Company for a second term of five years. 11. Special Resolution: To alter the Memorandum of Association. 12. Special Resolution: To adopt new Articles of Association. After all the agendas were taken up, the moderator from M/s. MUFG lntime Pvt. Ltd. was requested to facilitate the question-and-answer session with the registered speakers. fourteen members had registered as speakers for the 37th AGM. Out of them, seven members, Lavneesh Mohan from BIueocean Emerging India Fund 1, Shahi Jajn, Vlshal Prasad, Deepali Singhal from Perpetuity Health to Wealth (H2W) [Showing first 8,000 characters — download PDF for full document]